You are here


GSK says 'tailwinds' will lift its consumer healthcare business

UK drugmaker confident of staying ahead in the game even as generic drugs invade wellness segment

Trust in the products, as well as differentiation in safety, speed and efficacy, will help justify the premium over the generics, says Mr Ahmed (above).


CHEAPER generic drugs, which are growing in double-digits, are invading the wellness segment of the global consumer healthcare business in a big way, giving giant drugmakers such as GlaxoSmithKline (GSK) a run for their money.

In Australia, GSK's household-name drug